Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-08-24
Original SEC Filing: Click here

---

Webplus: SVA/20160824/6-K/2_EX-99.1/000.htm SEC Original: v447608_ex99-1.htm
Sinovac Reports Unaudited Second Quarter 2016 Financial Results BEIJING, August 23, 2016 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter ended June 30, 2016. Mr. Weidong Yin, Chairman, President and CEO of the Sinovac, commented, “As forecasted on our first quarter earnings call, we experienced a continued

---

---

Webplus: SVA/20160824/6-K/1/000.htm SEC Original: v447608_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2016-08-24CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085